The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging
Open accessAbstract
Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) is the acquisition of serial MRI images before, during, and after the administration of an MR contrast agent. Unlike conventional enhanced MRI, which simply provides a snapshot of enhancement at one point in time, DCE‐MRI permits a fuller depiction of the wash‐in and wash‐out contrast kinetics within tumors, and thus provides insight into the nature of the bulk tissue properties. Such data is readily amenable to two‐compartment pharmacokinetic modeling from which parameters based on the rates of exchange between the compartments can be generated. These parameters can be used to generate color‐encoded images that aid in the visual assessment of tumors. DCE‐MRI is used currently to characterize masses, stage tumors, and noninvasively monitor therapy. While DCE‐MRI is in clinical use, there are also a number of limitations, including overlap between malignant and benign inflammatory tissue, failure to resolve microscopic disease, and the inconsistent predictive value of enhancement pattern with regard to clinical outcome. Current research focuses on improving understanding of the meaning of DCE‐MRI at a molecular level, evaluating macromolecular and targeted contrast agents, and combining DCE‐MRI with other physiologic imaging techniques such as positron emission tomography. Efforts to standardize DCE‐MRI acquisition, analysis, and reporting methods will allow wider dissemination of this useful functional imaging technique. J. Magn. Reson. Imaging 2003;17:509–520. Published 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Self-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
THE THEORY AND APPLICATIONS OF THE EXCHANGE OF INERT GAS AT THE LUNGS AND TISSUES
KETY, S. S. (1951) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07246-1 · Cited by 1,663
Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
Tofts, P. S. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070113 · Cited by 1,478
Weissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles
Renkin, E. M. (1959) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1959.197.6.1205 · Cited by 723
Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging
Brix, G., Semmler, W., Port, R., Schad, L. R., Layer, G., & Lorenz, W. J. (1991) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199107000-00018 · Cited by 659
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography
Hoffmann, U., Brix, G., Knopp, M. V., Heβ, T., & Lorenz, W. J. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330408 · Cited by 303
Self-citationDaldrup, H., Shames, D. M., Wendland, M., Okuhata, Y., Link, T. M., Rosenau, W., Lu, Y., & Brasch, R. C. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.4.9762973 · Cited by 268
Assessing tumor angiogenesis using macromolecular MR imaging contrast media
Brasch, R., Pham, C., Shames, D., Roberts, T., Van Dijke, K., Van Bruggen, N., Mann, J., Ostrowitzki, S., & Melnyk, O. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070110 · Cited by 250
Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis
Dor, Y., Porat, R., & Keshet, E. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1367 · Cited by 237
Padhani, A. R., & Husband, J. E. (2001) · Clinical Radiology · doi:10.1053/crad.2001.0762 · Cited by 230
First experiences in screening women at high risk for breast cancer with MR imaging
Tilanus-Linthorst, M. M. A., Obdeijn, I. M. M., Bartels, K. C. M., de Koning, H. J., & Oudkerk, M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006480106487 · Cited by 216
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
Knopp, M. V., Giesel, F. L., Marcos, H. B., von Tengg‐Kobligk, H., & Choyke, P. L. (2001) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200108000-00006 · Cited by 215
Self-citationCooper, R. A., Carrington, B. M., Loncaster, J. A., Todd, S. M., Davidson, S. E., Logue, J. P., Luthra, A. D., Jones, A. P., Stratford, I., Hunter, R. D., et al. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00259-0 · Cited by 210
Mayr, N. A., Yuh, W. T. C., Magnotta, V. A., Ehrhardt, J. C., Wheeler, J. A., Sorosky, J. I., Davis, C. S., Wen, B.-C., Martin, D. D., Pelsang, R. E., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)85090-0 · Cited by 208
Pham, C. D., Roberts, T. P. L., Van Bruggen, N., Melnyk, O., Mann, J., Ferrara, N., Cohen, R. L., & Brasch, R. C. (1998) · Cancer Investigation · doi:10.3109/07357909809039771 · Cited by 208
Switch to the angiogenic phenotype during tumorigenesis.
Folkman, J., & Hanahan, D. (1991) · PubMed · Cited by 200
Reproducibility of quantitative dynamic MRI of normal human tissues
Padhani, A. R., Hayes, C., Landau, S., & Leach, M. O. (2002) · NMR in Biomedicine · doi:10.1002/nbm.732 · Cited by 188
Padhani, A. R., MacVicar, A. D., Gapinski, C. J., Dearnaley, D. P., Parker, G. J. M., John Suckling, A., Leach, M. O., & Husband, J. E. (2001) · Radiology · doi:10.1148/radiology.218.2.r01ja04365 · Cited by 155
Port, R. E., Knopp, M. V., Hoffmann, U., Milker-Zabel, S., & Brix, G. (1999) · Journal of Magnetic Resonance Imaging · Cited by 154
Self-citationFlickinger, F. W., Allison, J. D., Sherry, R. M., & Wright, J. C. (1993) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(93)90002-u · Cited by 148
Physiologic measurements by contrast‐enhanced MR imaging: Expectations and limitations
Roberts, T. P. L. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070112 · Cited by 135
Griffiths, J. R., Taylor, N. J., Howe, F. A., Saunders, M. I., Robinson, S. P., Hoskin, P., Powell, M. E. B., Thoumine, M., Caine, L. A., & Baddeley, H. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00326-x · Cited by 125
In vivo monitoring of tumor angiogenesis with MR imaging
Brasch, R. C., Li, K. C., Husband, J. E., Keogan, M. T., Neeman, M., Padhani, A. R., Shames, D. M., & Turetschek, K. (2000) · Academic Radiology · doi:10.1016/s1076-6332(00)80630-3 · Cited by 124
What Does Radiotherapy Do to Endothelial Cells?
Folkman, J., & Camphausen, K. A. (2001) · Science · doi:10.1126/science.1062892 · Cited by 95
Earlier detection of breast cancer by surveillance of women at familial risk.
Tilanus-Linthorst, M., Bartels, C., Obdeijn, A. I. M., & Oudkerk, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00337-8 · Cited by 91
Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow
Robinson, S. P., Howe, F. A., Rodrigues, L. M., Stubbs, M., & Griffiths, J. R. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80045-3 · Cited by 89
Turetschek, K., Roberts, T. P. L., Floyd, E., et al. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1126 · Cited by 76
Robinson, S. P., Rodrigues, L. M., Ojugo, A., McSheehy, P., Howe, F. A., & Griffiths, J. R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.172 · Cited by 74
Parker, G. J. M., Baustert, I. C., Tanner, S. F., et al. (2000) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(99)00124-1 · Cited by 43
Effect of Local Anti-VEGF Antibody Treatment on Tumor Microvessel Permeability
Lichtenbeld, H., Ferarra, N., Jain, R. K., & Munn, L. L. (1999) · Microvascular Research · doi:10.1006/mvre.1998.2140 · Cited by 38
Cited by
Deformable medical image registration: a survey
Sotiras, A., Davatzikos, C., & Paragios, N. (2013) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2013.2265603 · Cited by 1,587
“perfusion imaging for cancer characterization and treatment) that convey great clinical information and have important diagnostic value [3, 4].”
BackgroundKuhl, C. (2007) · Radiology · doi:10.1148/radiol.2442051620 · Cited by 778
Multimodality Molecular Imaging of Tumor Angiogenesis
Cai, W., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045922 · Cited by 494
Classic models for dynamic contrast‐enhanced MRI
Sourbron, S. P., & Buckley, D. L. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2940 · Cited by 434
Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5378 · Cited by 420
Metadata
- Authors
- Choyke, P. L., Dwyer, A. J., & Knopp, M. V.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2003-04-23
- Volume
- 17
- Issue
- 5
- Pages
- 509-520
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2161240017
- Cited by
- 439
- References
- 37
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.